Human M-CSF
Synonyms: CSF1

Recombinant human M-CSF can regulate the proliferation, differentiation, and survival of monocytes, macrophages, osteoclasts and their hematopoietic progenitors . The macrophage colony-stimulating factor (M-CSF) is a potent hematopoietic cytokine that is involved in diverse processes, such as regulation of inflammatory responses, bone resorption, atherosclerosis or brain and placental development. M-CSF recombinant protein can be especially used in differentiation studies, cell culture and functional assays.

Select a quality grade:
Select a size:
Other sizes

Related products for Human M-CSF

Specifications for Human M-CSF
Overview

Recombinant human M-CSF can regulate the proliferation, differentiation, and survival of monocytes, macrophages, osteoclasts and their hematopoietic progenitors . The macrophage colony-stimulating factor (M-CSF) is a potent hematopoietic cytokine that is involved in diverse processes, such as regulation of inflammatory responses, bone resorption, atherosclerosis or brain and placental development. M-CSF recombinant protein can be especially used in differentiation studies, cell culture and functional assays.

Applications

Human M-CSF can be used for a variety of applications, including:

  • Survival studies and apoptosis assays, for example, using peripheral blood monocytes.
  • Differentiation of macrophages from peripheral blood monocytes.
  • Differentiation of osteoclasts from CD14+ monocytes.
Alternative names

CSF1

Detailed product information

Biological activity

Determination method
Proliferation of NFS-60 cells (NIBSC 89/512)
Research grade
≥ 1×107 IU/mg
Premium grade
≥ 2×107 IU/mg (Typical activity 1.2×108 IU/mg)
We measure the biological activity of each batch of MACS Premium-Grade Cytokines and state the results in the Certificate of Analysis (CoA). Based on the lot-specific activity, exact doses of active cytokine can be applied to cell culture experiments. This allows for reproducible cell culture conditions without the need for time-consuming lot-to-lot testing.
Background information

Macrophage-colony stimulating factor (M-CSF), a four α-helical bundle cytokine, is a potent hematopoietic regulator. It is primarily produced by monocytes, granulocytes, endothelial cells, and fibroblasts. The main function of M-CSF is the regulation of proliferation, differentiation, and survival of monocytes, macrophages and their hematopoietic progenitors. Furthermore, M-CSF has been shown to play an important role in immunological defense, bone metabolism, fertility, and pregnancy.

Quality description

Research-grade cytokines are suitable for a wide variety of cell culture applications. They are sterile-filtered prior to lyophilization. Generally, endotoxin levels are <0.1 ng/μg (<1 EU/μg), and purities are >95%. The biological activity is tested in appropriate bioassays.

Premium-grade cytokines offer the convenience of high and well-defined biological activities and allow exact unit dosing for demanding applications. The biological activity is determined after lyophilization and reconstitution, and normalized to WHO/NIBSC standards whenever available. In general, endotoxin levels are <0.01 ng/μg (<0.1 EU/μg), and purities are >97%. Lot-specific activities are stated in the Certificate of Analysis (www. miltenyibiotec.com/certificates).

Product data and images for Human M-CSF
Figure 1

Human M-CSF activity assay. The biological activity of Human M-CSF is determined by proliferation assay using NFS-60 cells.

Figure 2

SDS-PAGE of Human M-CSF, premium grade under reducing (R) and non-reducing (NR) conditions.

Resources for Human M-CSF
Documents and Protocols
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for Human M-CSF
Publications
  1. Lahaye, X. et al. (2018) NONO Detects the Nuclear HIV Capsid to Promote cGAS-Mediated Innate Immune Activation. Cell 175 (2): 488-501
  2. Queval, C. J. et al. (2014) A microscopic phenotypic assay for the quantification of intracellular mycobacteria adapted for high-throughput/high-content screening. J. Vis. Exp. (83)
  3. Giroud, P. et al. (2020) Expression of TAM-R in human immune cells and unique regulatory function of MerTK in IL-10 production by tolerogenic DC. Front Immunol 11: 564133
  4. Meissner, F. et al. (2010) Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood 116 (9): 1570-1573
  5. Michelet, X. et al. (2015) MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b. J Immunol 194 (5): 2079-2088
  6. Hazlett, H. F. et al. (2020) Altered iron metabolism in cystic fibrosis macrophages: the impact of CFTR modulators and implications for Pseudomonas aeruginosa survival. Sci Rep 10 (1): 10935
  7. Fernandes, M. C. et al. (2016) Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. mBio. 7 (3)
  8. Dahlem, C. et al. (2020) Thioholgamide A, a New Anti-Proliferative Anti-Tumor Agent, Modulates Macrophage Polarization and Metabolism. Cancers (Basel) 12 (5): 1288
  9. Barosova, H. et al. (2020) Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment. J. Vis. Exp. (159)
  10. Wang, C. et al. (2010) Innate immune response to Mycobacterium tuberculosis Beijing and other genotypes. PLoS One 5 (10): e13594
  11. Guery, L. et al. (2014) Fine-tuning nucleophosmin in macrophage differentiation and activation. Blood 118: 4694-4704
  12. Wu, D. J. et al. (2014) A novel in vivo gene transfer technique and in vitro cell based assays for the study of bone loss in musculoskeletal disorders. J. Vis. Exp. (88): 51810
  13. Vogel, S. Z. et al. (2015) TCAIM decreases T cell priming capacity of dendritic cells by inhibiting TLR-induced Ca2+ influx and IL-2 production. J Immunol 194 (7): 3136-3146
  14. Bénéteau, M. et al. (2012) Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response. Proc. Natl. Acad. Sci. U.S.A. 109 (49): 20071-20076
  15. Hussen, K. A. et al. (2017) Molecular and Functional Characterization of Lymphoid Progenitor Subsets Reveals a Bipartite Architecture of Human Lymphopoiesis. Immunity 47 (4): 680-696
  16. Mire-Sluis, A. R. et al. (1995) The international standard for macrophage colony stimulating factor (M-CSF). Evaluation in an international collaborative study. J. Immunol. Methods 179: 141-151
  17. McEwan, W. A. et al. (2013) Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat Immunol 14 (4): 327-336
  18. Kusao, I. et al. (2021) Cognitive performance related to HIV-1-infected monocytes. J Neuropathol Exp Neurol. 24 (1): 71-80

You have previously chosen International as your location.
What do you want to do?